NEW YORK (GenomeWeb) – Claritas Genomics today announced it has secured $15 million in Series B financing.

The Cambridge, Mass.-based pediatric genetic testing services firm said that the funds would be used to expand commercial operations, launch next-generation sequencing-based tests to diagnose pediatric genetic disorders, and build its network of disease experts.

WuXi NextCode Genomics joined Series A investors Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and Cerner.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.